HER-2 Protein Vaccine in Treating Women With Breast Cancer

Completed · Phase 1

Conditions studied: Breast Cancer

In brief

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of HER-2 protein vaccine in treating women who have breast cancer.

Key facts

Study ID

NCT00068614

Run by

Case Comprehensive Cancer Center

Starts

2003-07-01

Last updated by the study team

2014-02-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Ireland Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.